Evidence map›Paper›PMID 25184564›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2014

Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

David Lebeaux, Jean-Marc Ghigo, Christophe Beloin

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 635 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
635citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

635 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. A systematic review of the use of bacteriophages for in vitro biofilm control.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mechanochemical Synthesis of a TiOJournal of functional biomaterials · 2026
    Article
  10. Characterization of Antibiotic-Tolerant Persister Cells inAnimals : an open access journal from MDPI · 2026
    Article
  11. Article
  12. Siderophore sharing protects clonalApplied and environmental microbiology · 2026
    Article
  13. Biofilm Formation and the Pore ProteinsAntibiotics (Basel, Switzerland) · 2026
    Article
  14. Comprehensive Phenotypic Characterization of ClinicalInternational journal of molecular sciences · 2026
    Article
  15. Article
  16. Contribution of sonication to the microbiology diagnosis of periprosthetic joint infection: Retrospective study of real-world data.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

575 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David LebeauxInstitut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie, Paris, France Université Paris Descartes, Sorbonne Paris Cité, AP-HP, Hôpital Necker Enfants Malades, Centre d'Infectiologie Necker-Pasteur and Institut Imagine, Paris, France.
Jean-Marc GhigoInstitut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie, Paris, France.
Christophe BeloinInstitut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie, Paris, France cbeloin@pasteur.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-associated microbial communities, called biofilms, are present in all environments. Although biofilms play an important positive role in a variety of ecosystems, they also have many negative effects, including biofilm-related infections in medical settings. The ability of pathogenic biofilms to survive in the presence of high concentrations of antibiotics is called "recalcitrance" and is a characteristic property of the biofilm lifestyle, leading to treatment failure and infection recurrence. This review presents our current understanding of the molecular mechanisms of biofilm recalcitrance toward antibiotics and describes how recent progress has improved our capacity to design original and efficient strategies to prevent or eradicate biofilm-related infections.

Indexed as

BiofilmsDrug Resistance, BacterialAnimalsAnti-Bacterial AgentsBacterial InfectionsCatheter-Related InfectionsEscherichia coliGenes, BacterialGene Transfer, HorizontalHumansMicrobial ViabilityPseudomonas aeruginosaAnti-Bacterial Agents

Identifiers

PMID25184564
PMCPMC4187679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.